DLBCL Cell of Origin: What Role Should It Play in Care Today?
Diffuse large B-cell lymphoma (DLBCL) is curable in about two-thirds of patients. Research has focused on determining which patients have less favorable prognoses so that they can be considered for novel targeted-treatment strategies. In 2000, gene expression profiling was used to define two princip...
| Published in: | Oncology (08909091) Vol. 32; no. 9; pp. 445 - 450 |
|---|---|
| Main Authors: | , |
| Format: | tables/charts Journal Article |
| Published: |
MJH Life Sciences
Sep2018
|
| Online Access: | View this record in EBSCOhost |